MedTrace Logo

Factors Predicting Persistence of Oncogenic HPV and Cervical Dysplasia in HIV Infected Kenyan Women

NCT04045652 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 223

Last updated 2024-07-17

No results posted yet for this study

Summary

This study will utilize a longitudinal study design to better understand the natural history of oncogenic Human Papillomavirus (HPV) infections in Human Immunodeficiency Virus (HIV)-infected and HIV-uninfected Kenyan women, including the potentially modifiable (and non-modifiable) factors that are associated with progression of oncogenic HPV infection to clinical disease, including cervical cancer.

Conditions

  • HIV/AIDS
  • Cervical Dysplasia
  • HIV Infections

Sponsors & Collaborators

  • Indiana University

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-09-21
Primary Completion
2020-11-05
Completion
2020-11-05

Countries

  • United States
  • Kenya
  • Uganda

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04045652 on ClinicalTrials.gov